% alzhub.org library filter
% Source: https://alzhub.org/research?author=Fagan+AM&about=brain-scans
% 22 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{handen2020-32775597,
  author  = {Handen, B. L. and Lott, I. T. and Christian, B. T. and Schupf, N. and OBryant, S. and Mapstone, M. and Fagan, A. M. and Lee, J. H. and others},
  title   = {{The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2020},
  doi     = {10.1002/dad2.12065},
  pmid    = {32775597},
  url     = {https://doi.org/10.1002/dad2.12065}
}

@article{roe2013-23576620,
  author  = {Roe, C. M. and Fagan, A. M. and Grant, E. A. and Hassenstab, J. and Moulder, K. L. and Maue Dreyfus, D. and Sutphen, C. L. and Benzinger, T. L. and others},
  title   = {{Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later}},
  journal = {Neurology},
  year    = {2013},
  doi     = {10.1212/wnl.0b013e3182918ca6},
  pmid    = {23576620},
  url     = {https://doi.org/10.1212/wnl.0b013e3182918ca6}
}

@article{gordon2016-27548756,
  author  = {Gordon, B. A. and Blazey, T. and Su, Y. and Fagan, A. M. and Holtzman, D. M. and Morris, J. C. and Benzinger, T. L.},
  title   = {{Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology}},
  journal = {JAMA neurology},
  year    = {2016},
  doi     = {10.1001/jamaneurol.2016.2642},
  pmid    = {27548756},
  url     = {https://doi.org/10.1001/jamaneurol.2016.2642}
}

@article{llibreguerra2019-31825500,
  author  = {Llibre-Guerra, J. J. and Li, Y. and Schindler, S. E. and Gordon, B. A. and Fagan, A. M. and Morris, J. C. and Benzinger, T. L. S. and Hassenstab, J. and others},
  title   = {{Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease}},
  journal = {JAMA network open},
  year    = {2019},
  doi     = {10.1001/jamanetworkopen.2019.17126},
  pmid    = {31825500},
  url     = {https://doi.org/10.1001/jamanetworkopen.2019.17126}
}

@article{reiman2012-23137948,
  author  = {Reiman, E. M. and Quiroz, Y. T. and Fleisher, A. S. and Chen, K. and Velez-Pardo, C. and Jimenez-Del-Rio, M. and Fagan, A. M. and Shah, A. R. and others},
  title   = {{Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70228-4},
  pmid    = {23137948},
  url     = {https://doi.org/10.1016/s1474-4422(12)70228-4}
}

@article{lee2016-27016429,
  author  = {Lee, S. and Viqar, F. and Zimmerman, M. E. and Narkhede, A. and Tosto, G. and Benzinger, T. L. and Marcus, D. S. and Fagan, A. M. and others},
  title   = {{White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network}},
  journal = {Annals of neurology},
  year    = {2016},
  doi     = {10.1002/ana.24647},
  pmid    = {27016429},
  url     = {https://doi.org/10.1002/ana.24647}
}

@article{morris2009-20008650,
  author  = {Morris, J. C. and Roe, C. M. and Grant, E. A. and Head, D. and Storandt, M. and Goate, A. M. and Fagan, A. M. and Holtzman, D. M. and others},
  title   = {{Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2009},
  doi     = {10.1001/archneurol.2009.269},
  pmid    = {20008650},
  url     = {https://doi.org/10.1001/archneurol.2009.269}
}

@article{xiong2022-35218143,
  author  = {Xiong, C. and Luo, J. and Schindler, S. E. and Fagan, A. M. and Benzinger, T. and Hassenstab, J. and Balls-Berry, J. E. and Agboola, F. and others},
  title   = {{Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2022},
  doi     = {10.1002/alz.12608},
  pmid    = {35218143},
  url     = {https://doi.org/10.1002/alz.12608}
}

@article{fagan2006-16372280,
  author  = {Fagan, A. M. and Mintun, M. A. and Mach, R. H. and Lee, S. Y. and Dence, C. S. and Shah, A. R. and LaRossa, G. N. and Spinner, M. L. and others},
  title   = {{Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans}},
  journal = {Annals of neurology},
  year    = {2006},
  doi     = {10.1002/ana.20730},
  pmid    = {16372280},
  url     = {https://doi.org/10.1002/ana.20730}
}

@article{tarawneh2011-21823155,
  author  = {Tarawneh, R. and D'Angelo, G. and Macy, E. and Xiong, C. and Carter, D. and Cairns, N. J. and Fagan, A. M. and Head, D. and others},
  title   = {{Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease}},
  journal = {Annals of neurology},
  year    = {2011},
  doi     = {10.1002/ana.22448},
  pmid    = {21823155},
  url     = {https://doi.org/10.1002/ana.22448}
}

@article{fagan2011-21555603,
  author  = {Fagan, A. M. and Shaw, L. M. and Xiong, C. and Vanderstichele, H. and Mintun, M. A. and Trojanowski, J. Q. and Coart, E. and Morris, J. C. and others},
  title   = {{Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2011.105},
  pmid    = {21555603},
  url     = {https://doi.org/10.1001/archneurol.2011.105}
}

@article{wang2018-30569014,
  author  = {Wang, G. and Xiong, C. and McDade, E. M. and Hassenstab, J. and Aschenbrenner, A. J. and Fagan, A. M. and Benzinger, T. L. S. and Gordon, B. A. and others},
  title   = {{Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.10.009},
  pmid    = {30569014},
  url     = {https://doi.org/10.1016/j.trci.2018.10.009}
}

@article{lajoie2018-29282337,
  author  = {La Joie, R. and Bejanin, A. and Fagan, A. M. and Ayakta, N. and Baker, S. L. and Bourakova, V. and Boxer, A. L. and Cha, J. and others},
  title   = {{Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000004860},
  pmid    = {29282337},
  url     = {https://doi.org/10.1212/wnl.0000000000004860}
}

@article{millar2023-36607335,
  author  = {Millar, P. R. and Gordon, B. A. and Luckett, P. H. and Benzinger, T. L. S. and Cruchaga, C. and Fagan, A. M. and Hassenstab, J. J. and Perrin, R. J. and others},
  title   = {{Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study}},
  journal = {eLife},
  year    = {2023},
  doi     = {10.7554/elife.81869},
  pmid    = {36607335},
  url     = {https://doi.org/10.7554/elife.81869}
}

@article{luo2023-37202169,
  author  = {Luo, J. and Ma, Y. and Agboola, F. J. and Grant, E. and Morris, J. C. and McDade, E. and Fagan, A. M. and Benzinger, T. L. S. and others},
  title   = {{Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207378},
  pmid    = {37202169},
  url     = {https://doi.org/10.1212/wnl.0000000000207378}
}

@article{lucey2019-30626715,
  author  = {Lucey, B. P. and McCullough, A. and Landsness, E. C. and Toedebusch, C. D. and McLeland, J. S. and Zaza, A. M. and Fagan, A. M. and McCue, L. and others},
  title   = {{Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease}},
  journal = {Science translational medicine},
  year    = {2019},
  doi     = {10.1126/scitranslmed.aau6550},
  pmid    = {30626715},
  url     = {https://doi.org/10.1126/scitranslmed.aau6550}
}

@article{wang2013-23959173,
  author  = {Wang, L. and Brier, M. R. and Snyder, A. Z. and Thomas, J. B. and Fagan, A. M. and Xiong, C. and Benzinger, T. L. and Holtzman, D. M. and others},
  title   = {{Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity}},
  journal = {JAMA neurology},
  year    = {2013},
  doi     = {10.1001/jamaneurol.2013.3253},
  pmid    = {23959173},
  url     = {https://doi.org/10.1001/jamaneurol.2013.3253}
}

@article{meeker2022-35167933,
  author  = {Meeker, K. L. and Butt, O. H. and Gordon, B. A. and Fagan, A. M. and Schindler, S. E. and Morris, J. C. and Benzinger, T. L. S. and Ances, B. M.},
  title   = {{Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage}},
  journal = {Neurobiology of disease},
  year    = {2022},
  doi     = {10.1016/j.nbd.2022.105662},
  pmid    = {35167933},
  url     = {https://doi.org/10.1016/j.nbd.2022.105662}
}

@article{cairns2009-20008664,
  author  = {Cairns, N. J. and Ikonomovic, M. D. and Benzinger, T. and Storandt, M. and Fagan, A. M. and Shah, A. R. and Reinwald, L. T. and Carter, D. and others},
  title   = {{Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report}},
  journal = {Archives of neurology},
  year    = {2009},
  doi     = {10.1001/archneurol.2009.279},
  pmid    = {20008664},
  url     = {https://doi.org/10.1001/archneurol.2009.279}
}

@article{wang2015-25716355,
  author  = {Wang, L. and Benzinger, T. L. and Hassenstab, J. and Blazey, T. and Owen, C. and Liu, J. and Fagan, A. M. and Morris, J. C. and others},
  title   = {{Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000001401},
  pmid    = {25716355},
  url     = {https://doi.org/10.1212/wnl.0000000000001401}
}

@article{fagan2009-19260027,
  author  = {Fagan, A. M. and Head, D. and Shah, A. R. and Marcus, D. and Mintun, M. and Morris, J. C. and Holtzman, D. M.},
  title   = {{Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly}},
  journal = {Annals of neurology},
  year    = {2009},
  doi     = {10.1002/ana.21559},
  pmid    = {19260027},
  url     = {https://doi.org/10.1002/ana.21559}
}

@article{millar2020-33039901,
  author  = {Millar, P. R. and Ances, B. M. and Gordon, B. A. and Benzinger, T. L. S. and Fagan, A. M. and Morris, J. C. and Balota, D. A.},
  title   = {{Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease}},
  journal = {Neurobiology of aging},
  year    = {2020},
  doi     = {10.1016/j.neurobiolaging.2020.08.007},
  pmid    = {33039901},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2020.08.007}
}